Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-29 | Mr. Matricaria, 73, was appointed to the Board in March 2014. He has more than 35 years of medical device and pharmaceutical experience at St. Jude Medical, Inc. and Eli Lilly and Company, Inc. ... The Chairman is paid an annual retainer of $150,000 for service in this role. ... The following table provides information regarding compensation to non-employee directors who served during the fiscal year ended December 31, 2015. Ronald A. Matricaria Fees Earned or Paid in Cash ($) 150,000, Restricted Stock Awards (Number of Shares Granted) 8,000, Grant Date Fair Value of Restricted Stock Awards ($) 264,960, Total ($) 414,960. |
| 2017-04-28 | Mr. Matricaria, 74, was appointed to the Board in March 2014. He has more than 35 years of medical device and pharmaceutical experience... The Chairman is paid an annual retainer of $150,000 for service in this role. ... The following table provides information regarding the 2016 compensation of non-employee directors. Ronald A. Matricaria: Fees Earned or Paid in Cash ($) 150,000, Restricted Stock Awards (Number of Shares Granted) 7,200, Grant Date Fair Value of Restricted Stock Awards ($) 319,608, Total ($) 469,608. |
| 2019-04-29 | Mr. Matricaria, 76, was appointed to the Board in March 2014. He has more than 35 years of medical device and pharmaceutical experience at St. Jude Medical, Inc. and Eli Lilly and Company, Inc. ... The Board believes that Mr. Matricaria’s wealth of experience as both an executive and director in the medical device industry brings invaluable experience and leadership qualities to the Board. ... The following table provides information regarding the 2018 compensation of non-employee directors. ... Ronald A. Matricaria 150,000 fees earned or paid in cash, 5,274 restricted stock awards, 299,985 grant date fair value of restricted stock awards, total 449,985. |
| 2020-04-29 | Mr. Matricaria, 77, was appointed to the Board in March 2014. He has more than 35 years of medical device and pharmaceutical experience... The Board believes that Mr. Matricaria’s wealth of experience as both an executive and director in the medical device industry brings invaluable experience and leadership qualities to the Board. ... The following table provides information regarding the 2019 compensation of non-employee directors. ... Ronald A. Matricaria 160,000 fees earned in cash, 6,373 restricted stock awards, 325,023 grant date fair value of restricted stock awards, total 485,023. |
| 2021-04-29 | Ronald A. Matricaria CurrentChairman of the Board (Not Standing for Re-Election as Director at the Annual Meeting – Board Membership Ending as of the Annual Meeting) Mr. Matricaria, 78, was appointed to the Board in March 2014... The Board believes that Mr. Matricaria’s wealth of experience as both an executive and director in the medical device industry brings invaluable experience and leadership qualities to the Board. The following table provides information regarding the 2020 compensation of non-employee directors. Ronald A. Matricaria Fees Earned or Paid in Cash: 154,667 Restricted Stock Unit Awards: 8,520 Grant Date Fair Value of Restricted Stock Awards: 325,038 Total: 479,705 |
Data sourced from SEC filings. Last updated: 2026-02-03